Market Tracker

02/21 5:16pm ET

Chembio Diagnostics Inc (NASDAQ:CEMI)

6.15
Delayed Data
As of Feb 21
 +0.10 / +1.65%
Today’s Change
5.08
Today|||52-Week Range
9.40
-9.56%
Year-to-Date
No recent news for Chembio Diagnostics Inc.

Today’s Trading

Previous close6.05
Today’s open6.08
Day’s range6.05 - 6.15
Volume25,846
Average volume (3 months)23,810
Market cap$72.8M
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)-108.33%
Earnings growth (this year)-380.00%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-12.26%
P/E ratioNM
Price/Sales2.12
Price/Book3.30

Competitors

 Today’s
change
Today’s
% change
IPCIIntellipharmaceutics...-0.05-2.04%
BLRXBioLine RX Ltd+0.04+3.16%
PULMPulmatrix Inc-0.42-10.47%
AGRXAgile Therapeutics I...-0.07-2.82%
Data as of 4:00pm ET, 02/21/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$24.3M
Annual profit (last year)-$2.4M
Net profit margin-9.88%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
John J. Sperzel
Chief Financial &
Accounting Officer
Richard J. Larkin
Corporate headquarters
Medford, New York

Forecasts